← Leaderboards
Artin Perse
Pillsmart Inc.
$379,072
Attributed
$379,072
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $324.1K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
NIH$379,072 · 1
By mechanism
R43$379,072 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Evidence Base”
- Chanza Baytop · Westat, Inc.$271,217,917
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Susan M Landau · University Of California Berkeley$47,252,026
- Abraham Aizer Brody · New York University School Of Medicine$44,858,181
- Greg Yothers · University Of Chicago$29,898,807
- John H Alexander · Duke University$22,057,000
Research focus
Evidence BaseMedication ComplianceDesignEnsureInteroperabilityMedical DeviceAttentionAdolescentDoseEngineeringFeasibility TestingImpulsivityMarket ResearchCaregiver BurdenCaregiversCaregiver SupportChildAttention Deficit Hyperactivity DisorderDevicesClinical TrialsBehavioralElderlyAdherenceMedication Management
Grant awards (2)
Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers$55,000
R43 · FY2022 · DA · contact PI
Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers$324,072
R43 · FY2021 · DA · contact PI